• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性冠状动脉疾病管理中的种族和民族差异。

Racial and Ethnic Disparities in the Management of Chronic Coronary Disease.

机构信息

Department of Medicine, Stanford University, 300 Pasteur Drive, L154, Stanford, CA 94305-5133, USA.

Division of Cardiovascular Medicine and Cardiovascular Institute, Department of Medicine, Center for Academic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Med Clin North Am. 2024 May;108(3):595-607. doi: 10.1016/j.mcna.2023.11.008. Epub 2023 Dec 19.

DOI:10.1016/j.mcna.2023.11.008
PMID:38548466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10979033/
Abstract

Chronic coronary disease (CCD) comprises a continuum of conditions that include obstructive and non-obstructive coronary artery disease with or without prior acute coronary syndrome. Racial and ethnic representation disparities are pervasive in CCD guideline-informing clinical trials and evidence-based management. These disparities manifest across the entire spectrum of CCD management, spanning from non-pharmacological lifestyle changes to guideline-directed medical therapy, and cardiac rehabilitation to invasive procedures. Recognizing and addressing the historical factors underlying these disparities is crucial for enhancing the quality and equity of CCD management within an increasingly diverse population.

摘要

慢性冠状动脉疾病(CCD)包括一系列病症,包括有或无先前急性冠状动脉综合征的阻塞性和非阻塞性冠状动脉疾病。在指导 CCD 临床实践和循证管理的指南制定相关临床试验中,存在着普遍的种族和民族代表性差异。这些差异贯穿于 CCD 管理的整个范围,从非药物生活方式改变到指南指导的药物治疗,以及心脏康复到有创性操作。认识和解决这些差异背后的历史因素对于提高在日益多样化的人群中 CCD 管理的质量和公平性至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17d/10979033/d993ad540b72/nihms-1951504-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17d/10979033/d993ad540b72/nihms-1951504-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d17d/10979033/d993ad540b72/nihms-1951504-f0001.jpg

相似文献

1
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease.慢性冠状动脉疾病管理中的种族和民族差异。
Med Clin North Am. 2024 May;108(3):595-607. doi: 10.1016/j.mcna.2023.11.008. Epub 2023 Dec 19.
2
Racial and Ethnic Minorities Underrepresented in Pain Management Guidelines for Total Joint Arthroplasty: A Meta-analysis.在全膝关节置换术疼痛管理指南中代表性不足的少数族裔:一项荟萃分析。
Clin Orthop Relat Res. 2024 Sep 1;482(9):1698-1706. doi: 10.1097/CORR.0000000000003026. Epub 2024 Mar 18.
3
Strategies to Address Racial and Ethnic Disparities in Health and Health Care for Chronic Conditions : An Evidence Map of Research From 2017 to 2024.解决慢性病健康与医疗保健方面种族和族裔差异的策略:2017年至2024年研究证据图谱
Ann Intern Med. 2025 Jan;178(1):88-97. doi: 10.7326/ANNALS-24-01262. Epub 2024 Dec 17.
4
Racial/Ethnic Differences in Psychiatric and Medical Diagnoses Among Autistic Adults.成年自闭症患者精神科和医学诊断中的种族/民族差异。
Autism Adulthood. 2022 Dec 1;4(4):290-305. doi: 10.1089/aut.2021.0083. Epub 2022 Dec 13.
5
Disparities in utilization of coronary artery disease treatment by gender, race, and ethnicity: opportunities for prevention.按性别、种族和族裔划分的冠状动脉疾病治疗利用情况差异:预防机会
J Natl Black Nurses Assoc. 2007 Jul;18(1):36-49.
6
Racial Disparities in Ion Channelopathies and Inherited Cardiovascular Diseases Associated With Sudden Cardiac Death.种族差异与离子通道病和遗传性心血管疾病相关的心脏性猝死。
J Am Heart Assoc. 2022 Mar 15;11(6):e023446. doi: 10.1161/JAHA.121.023446. Epub 2022 Mar 4.
7
Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.探讨结肠癌管理中种族/民族差异的复杂性和范围。
Int J Equity Health. 2023 Apr 14;22(1):68. doi: 10.1186/s12939-023-01883-w.
8
Racial and Ethnic Disparities in Management and Outcomes of Cardiac Arrest Complicating Acute Myocardial Infarction.种族和民族差异对急性心肌梗死并发心搏骤停的处理和结局的影响。
J Am Heart Assoc. 2021 Jun;10(11):e019907. doi: 10.1161/JAHA.120.019907. Epub 2021 May 20.
9
Toward representative genomic research: the children's rare disease cohorts experience.迈向具有代表性的基因组研究:儿童罕见病队列研究经验
Ther Adv Rare Dis. 2023 Aug 22;4:26330040231181406. doi: 10.1177/26330040231181406. eCollection 2023 Jan-Dec.
10
Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.美国 2000-19 年按县、种族和民族划分的特定原因死亡率:健康差距的系统分析。
Lancet. 2023 Sep 23;402(10407):1065-1082. doi: 10.1016/S0140-6736(23)01088-7. Epub 2023 Aug 3.

引用本文的文献

1
Racial and Ethnic Disparity in Healthcare Expenditure and Resource Utilization Among Patients with Cardiovascular Diseases.心血管疾病患者医疗支出与资源利用中的种族和族裔差异
J Racial Ethn Health Disparities. 2024 Aug 14. doi: 10.1007/s40615-024-02125-7.

本文引用的文献

1
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
2
Supplemental Nutrition Assistance Program Access and Racial Disparities in Food Insecurity.补充营养援助计划的获得情况与粮食不安全方面的种族差异。
JAMA Netw Open. 2023 Jun 1;6(6):e2320196. doi: 10.1001/jamanetworkopen.2023.20196.
3
The Problem With Race-Based Medicine.
基于种族的医学问题。
Am J Phys Med Rehabil. 2023 Jul 1;102(7):567-570. doi: 10.1097/PHM.0000000000002251.
4
Residing in a Food Desert and Adverse Cardiovascular Events in US Veterans With Established Cardiovascular Disease.居住在食物荒漠与美国有明确心血管疾病病史退伍军人不良心血管事件的相关性研究。
Am J Cardiol. 2023 Jun 1;196:70-76. doi: 10.1016/j.amjcard.2023.03.010. Epub 2023 Apr 23.
5
Why Diverse Clinical Trial Participation Matters.为何多样化的临床试验参与至关重要。
N Engl J Med. 2023 Apr 6;388(14):1252-1254. doi: 10.1056/NEJMp2215609. Epub 2023 Apr 1.
6
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.美国按种族、民族和 10 年疾病风险划分的他汀类药物用于动脉粥样硬化性心血管疾病一级预防的流行情况:2013 年至 2020 年 3 月全国健康和营养调查。
JAMA Cardiol. 2023 May 1;8(5):443-452. doi: 10.1001/jamacardio.2023.0228.
7
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.贝匹地酸在他汀类药物不耐受患者中的心血管结局。
N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4.
8
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.稳定型缺血性心脏病患者管理模式的演变:JACC 本周综述主题。
J Am Coll Cardiol. 2023 Feb 7;81(5):505-514. doi: 10.1016/j.jacc.2022.08.814.
9
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
10
Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure.心血管疾病或心力衰竭新诊断后,医疗保险参保成年人中 GLP-1 受体激动剂和 SGLT2i 早期应用的不足和差异。
Diabetes Care. 2023 Jan 1;46(1):65-74. doi: 10.2337/dc22-0383.